Vaccination News

The CDC’s vaccine advisory committee voted Thursday to approve the addition of COVID-19 vaccines to the recommended childhood immunization schedule.

WASHINGTON — Pediatric influenza vaccination rates remain suboptimal compared with other childhood vaccines, and parents are even less concerned about influenza since the start of the COVID-19 pandemic, according to data reported here.

The FDA authorized a booster shot of Novavax’s COVID-19 vaccine, giving the United States an option for people who cannot or will not receive a messenger RNA vaccine.

WASHINGTON — Since its start 25 years ago, the varicella vaccine program in the United States has led to high vaccination coverage, resulting in a 97% decrease in cases of the disease also known as chickenpox, according to data presented at IDWeek.

Adults who are part of underrepresented racial and ethnic groups are less likely to be vaccinated against influenza and are more likely to be hospitalized for it, according to health officials.

Early data from a phase 2/3 trial suggest that the new Pfizer and BioNTech omicron booster increases protective antibodies against the BA.5 subvariant in adults 7 days after administration.

ANAHEIM, Calif. — It may be necessary to reframe vaccines to help reverse a downward trend in the rate of routine childhood immunizations, a speaker said at the AAP National Conference & Exhibition.

Early data from trials assessing the new Pfizer and BioNTech omicron-adapted booster vaccine show that the vaccine substantially increased protective antibodies against the BA.5 subvariant in adults.

The FDA has granted an emergency use authorization for booster doses of Moderna and Pfizer-BioNTech’s omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines for children and adolescents, both companies announced today.

Myocarditis and pericarditis after COVID-19 vaccination is rare across demographic groups and most likely to occur in teen boys in the week after their second shot of a two-dose vaccine, according to a study.